-
-
RELEUKO
- QTY 5.46
- 480MCG/0.8
- Syringe
FILGRASTIM, G-CSF (fil GRA stim) is a granulocyte colony-stimulating factor that stimulates the growth of neutrophils, a type of white blood cell (WBC) important in the body's fight against infection. It is used to reduce the incidence of fever and infection in patients with certain types of cancer who are receiving chemotherapy that affects the bone marrow, to stimulate blood cell production for removal of WBCs from the body prior to a bone marrow transplantation, to reduce the incidence of fever and infection in patients who have severe chronic neutropenia, and to improve survival outcomes following high-dose radiation exposure that is toxic to the bone marrow.
Change Location
Set Price Drop Alert for:
RELEUKO
- QTY 5.46
- 480MCG/0.8
- Syringe
More Ways to Save On:
RELEUKO
- QTY 5.46
- 480MCG/0.8
- Syringe
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
- Change Form
Medicine Chest
RELEUKO Information
En Español
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
